SCHEMBL9760868

SCHEMBL9760868

CNC(=O)c1cc(C(=O)c2ccccc2)ccc1[N+](=O)[O-]

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 1/20 0.59
VCAM1 P19320 1/20 0.56
CDC25B P30305 1/20 0.52
SLC6A2 P23975 2/20 0.49
SLC6A4 P31645 2/20 0.49
SLC6A3 Q01959 2/20 0.49
KDM4E B2RXH2 2/20 0.48
GLA P06280 1/20 0.48
ALDH1A1 P00352 3/20 0.48
POLB P06746 2/20 0.46
GAA P10253 2/20 0.46
MAPT P10636 1/20 0.46
HPGD P15428 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
HCAR3 P49019 1/20 0.46
CES2 O00748 1/20 0.46
CES1 P23141 1/20 0.46
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
CYP19A1 P11511 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9760976 0.84 HPGD (0.59) MAPK1VCAM1ALDH1A1POLBGAA
SCHEMBL17973446 0.84 MAPK1 (0.64) MAPK1VCAM1CDC25BKDM4EGLA
SCHEMBL9199250 0.84 MAPK1 (0.68) MAPK1VCAM1CDC25BKDM4EGLA
SCHEMBL9196396 0.81 MAPK1 (0.68) MAPK1VCAM1CDC25BKDM4EGLA
SCHEMBL9198295 0.81 MAPK1 (0.64) MAPK1VCAM1CDC25BKDM4EGLA
SCHEMBL27711812 0.80 MAPK1 (0.62) MAPK1VCAM1CDC25BKDM4EGLA
SCHEMBL9759904 0.80 BRAF (0.55) MAPK1KDM4EALDH1A1POLBGAA
SCHEMBL11301800 0.79 MAPK1 (0.59) MAPK1VCAM1CDC25BKDM4EGLA
SCHEMBL11014183 0.79 MAPK1 (0.73) MAPK1VCAM1CDC25BSLC6A2SLC6A3
SCHEMBL5981573 0.78 TSHR (0.71) MAPK1VCAM1KDM4EALDH1A1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1036002-C A process for preparing (1H-azol-1-ylmethyl) substituted quinazoline derivatives JANSSEN PHARMACEUTICA NV (BE) 1997-10-01 CN disclosed
CN-1033752-C (1H-azol-1-ylmethyl) substituted quinoline or quinolinone derivatives JANSSEN PHARMACEUTICA NV (SE) 1997-01-08 CN disclosed
CN-1106004-A A process for preparing (1H-azol-1-ylmethyl) substituted quinazoline derivatives JANSSEN PHARMACEUTICA NV (BE) 1995-08-02 CN disclosed
CN-1106005-A A process for preparing (1H-azol-1-ylmethyl) substituted quinoxaline derivatives JANSSEN PHARMACEUTICA NV (BE) 1995-08-02 CN disclosed
US-5037829-A Antitumor Activity; Androgen, Estrogen Inhibitors; Suppress The Plasma Elimination Of Retinoids JANSSEN PHARMACEUTICA N.V. (BE) 1991-08-06 US disclosed
CN-1042912-A (1H-oxazol-1-ylmethyl) substituted quinoline, quinazoline or quinoxaline derivatives JANSSEN PHARMACEUTICA NV (BE) 1990-06-13 CN disclosed